The global eClinical solutions market size was estimated at USD 3.84 billion in 2016. It is expected to post a CAGR of 13.6% over the forecast period. Increasing research and development activities by biopharma and pharma companies is one of the key trends escalating market growth. Besides this, growing incorporation of software solutions in clinical trials is also projected to provide a fillip to the market.
Burgeoning trend of outsourcing clinical trials to contract research organizations (CROs) along with rising number of CROs and life sciences organizations is poised to help the market gain tremendous traction in the coming years. In addition, growing research programs in Asian countries and development of cost-effective modules are anticipated to stir up the demand for eClinical solutions.
Moreover, presence of stringent regulatory structure for clinical trials and heightened need for safety monitoring are playing a vital role in the growth of the market in developed economies such as the U.S. For instance, the U.S. Department of Health and Human Services and the National Institutes of Health are tightening clinical trial registration requirements and promoting clinical data sharing.
Surging demand for software solutions for clinical trials by pharma and biopharma companies is one of the primary growth stimulants of the market. Apart from this, increasing government grants to substantiate trials and widening end-user base for eClinical solutions are likely to boost the market during the review period.
eCOA is estimated to be the fastest growing segment during the forecast period owing to rising significance of high-quality clinical data. eCOA facilitates preservation of overall quality and is being increasingly incorporated in measurement of patient-reported, clinician-reported, and observer-reported outcomes. Data capturing process using eCOA platforms improves quality of information captured, streamline data collection procedures, and offers effective data analysis.
Soaring need for patient compliance is further pushing usage of eCOA solutions, which can effectively meet challenges posed by paper-based records. Elimination of data variance risk streamlined information and lowering of site monitoring cost are key advantages associated with eCOA. These aforementioned benefits are expected to fuel its demand in the coming years. Moreover, need for integration of patient care with clinical research studies, which leads to a more patient-centric approach, is projected to supplement the growth of the segment.
Web-hosted solutions dominated the market in 2016. The dominance of the segment can be attributed to associated benefits such as easy accessibility, usability, and lower investments required. Web-hosted products are easily customizable, owing to which, providers can customize presentation of information for different user groups. Additionally, these products have a greater level of interoperability. The segment is poised to maintain its position throughout the forecast period.
Cloud-based systems are anticipated to exhibit an exponential CAGR during the forecast period owing to integrated features such as flexibility, high accessibility, negligible handling costs, and easy data backup. Real-time data is available through these systems, which enables users to take quick decisions and provide high-quality information for risk-based monitoring. These associated advantages are anticipated to bolster the demand for cloud-based systems.
On the basis of development phase, the phase III segment is likely to lead the eClinical solutions market throughout the forecast period. Spiraling need for incorporation of clinical data management software to curb overall cost and improve process efficiency is contributing to the growth of the segment. Increasing number of drugs successfully reaching phase III is providing a significant push to the growth of the segment. Phase III involves the study of efficacy of a drug by using a group of more than 1,000 patients. The complexity of the study increases with increase in the number of patients, which triggers the demand for computer-based systems for data management, thereby revving up the adoption of eClinical solutions.
Phase I is estimated to be the most promising segment during the forecast period owing to high significance of these systems to predict future outcomes and eliminate drug candidates possessing least probability of success. Developments in biological modeling systems and personalized medicine technologies are leading to a boom in development of newer drugs. A large number of phase I trials and complex management and analysis of data acquired during various studies is expected to propel the growth of the segment.
CROs held the largest share in the market in 2016. The segment is projected to rise at a remarkable CAGR during the forecast period owing to growing inclination of pharmaceutical companies to reduce overall expenditure. Rising usage of eClinical solutions in research is further widening the scope of segment growth.
Benefits involved in outsourcing clinical trials to CROs are responsible for heightened growth of this segment. These benefits include cost advantages, increased efficiency of services, enhanced productivity, and higher focus on core areas of development critical to a company’s growth.
North America was the leading revenue contributor in 2016. Increasing target population, coupled with rising prevalence of lifestyle-associated diseases such as diabetes and cardiac disorders, is poised to stimulate the growth of the market. Moreover, domicile of prominent players and availability of sophisticated infrastructure are anticipated to accentuate the growth of the regional market.
Asia Pacific is likely to register a noteworthy CAGR over the forecast period. High unmet medical needs and rising prevalence of target chronic diseases such as cancer, cardiovascular conditions, and infectious diseases are stoking the demand for software solutions in the region. Increasing number of trials are outsourced to countries such as China, India, Korea, and Japan owing to a large patient population and low cost. This outsourcing has, thereby, boosted the adoption of eClinical solutions in these regions. As an emerging economy, the growth of the APAC market is largely driven by government funding related to research and drug discovery, which is estimated to enhance its growth over the forecast period.
Some of the major players in the market are IBM Watson Health; Oracle Corporation; Medidata Solutions Inc.; BioClinica; DATATRAK International, Inc.; PAREXEL International Corporation; CRF Health; ERT; eClinical Solutions; and OmniComm Systems Inc. These players are involved in various growth strategies such as new product development, mergers and acquisitions, and collaborations, which are helping them consolidate their position in the market. For instance, in February 2018, OmniComm Systems acquired Algorics to enhance its product portfolio with advanced data analytical capabilities.
Earlier in January 2018, OmniComm Systems entered into a partnership with Celerion with an aim to improve the efficiency of its clinical trials, patient safety, and improved outcomes. In May 2016, CRF Health announced revamping of its real-time portal, TrialManager, which is used for assessment and management of collected data during research studies. High operational cost, stringent regulatory framework, and capital requirement keep entry barriers at a higher level, owing to which, the threat of new entrants is expected to be low.
Base year for estimation
Actual estimates/Historical data
2014 - 2016
2017 - 2025
Revenue in USD Million and CAGR from 2017 to 2025
North America, Europe, Asia Pacific, Latin America, Middle East & Africa
U.S., Canada, Germany, U.K., France, Italy, Spain, Netherlands, Denmark, Sweden, Japan, China, India, Korea, Australia, New Zealand, Taiwan, Hong Kong, Singapore, Thailand, Vietnam, Brazil, Argentina, Chile, Mexico, South Africa, Saudi Arabia, U.A.E, Egypt, Qatar
Revenue forecast, company share, competitive landscape, growth factors, and trends
15% free customization scope (equivalent to 5 analysts working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional, & country levels, and provides an analysis of the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the eClinical solutions market report on the basis of product, delivery mode, development phase, end use, and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
EDC & CDMS
Clinical analytics platforms
Clinical data integration platforms
Delivery Mode Outlook (Revenue, USD Million, 2014 - 2025)
Licensed Enterprise (on premise)
Clinical Trials Outlook (Revenue, USD Million, 2014 - 2025)
End-use Outlook (Revenue, USD Million, 2014 - 2025)
Pharma & Biotech Organizations
Medical Device Manufacturers
Regional Outlook (Revenue, USD Million, 2014 - 2025)
Middle East & Africa
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."